Understanding caregiver experiences with disease-modifying therapies for spinal muscular atrophy: a qualitative study

Conclusion The caregiver experience with SMA has been transformed by the advent of disease-modifying therapies. Consistent and predictable access to disease-modifying therapies is a major concern for caregivers of children with SMA but is influenced by regulatory approvals, funding and eligibility criteria that are heterogenous across jurisdictions. Many caregivers described going to great lengths to access therapies, highlighting issues related to justice, such as equity and access. This diverse population reflects contemporary patients and families with SMA; their broad experiences may inform the healthcare delivery of other emerging orphan drugs.
Source: Archives of Disease in Childhood - Category: Pediatrics Authors: Tags: Editor's choice Original research Source Type: research